Clinical Trials Arena via Yahoo
Merck’s trial of KEYTRUDA regimen fails to meet primary endpoint
According to the data from an interim analysis by an independent Data Monitoring Committee, KEYTRUDA regimen failed to show DFS improvement versus placebo. The secondary goal of OS was not tested ...
46 minutes ago